La ISPE ha anunciado los nombres de la nueva junta directiva, que será presentada en el Annual Meeting de 2007. La nueva junta, que empezará a ejercer a partir del día 6 de Noviembre, estará compuesta por:
Presidente de la junta:
Bruce Davis, Global Capital Director, AstraZeneca, Cheshire, United Kingdom
Vice presidente:
Charles P. Hoiberg, PhD, Pfizer, Executive Director, Regulatory CMC - Policy and Regulatory Environment group, Maryland, U.S.
Tresorero:
Alan Mac Neice, Project Director for Biologics, Elan’s Biopharmaceutical Science, Athlone, Ireland
Secretario:
Andre Walker, Director of Manufacturing Engineering, Biogen Idec’s Commercial and Clinical Operations, Massachusetts, U.S.
Nuevos Directores:
Nuala Calnan, Principal Consultant, Project Management Group, Dublin, Ireland
Charlotte Enghave, PhD, Senior Consultant, Finished Product Department, NNE Pharmaplan, Soeberg, Denmark
Nigel Frost, Managing Director, Thermal Transfer Ltd., Derbyshire, United Kingdom
Damian Greene, Director/Team Leader, Pfizer Global Manufacturing (PGM), New York, U.S.
David E. Petko, PE, Senior Director, Auxilium Pharmaceuticals, Inc., Pennsylvania, U.S.
Directores reelegidos
Arthur (Randy) Perez, PhD, Executive Expert, IT Quality Assurance, Novartis Pharmaceuticals Corp., New Jersey, U.S.
Stephanie Wilkins, PE, President, PharmaConsult US, Inc., New Jersey, U.S.
Los siguientes Directores fueron elegidos en 2006 por 2 años:
Jane R. Brown, (Past Chairman), Manager, GMP Compliance, GlaxoSmithKline, North Carolina, U.S.
Joan Gore, Manager, CT Planning/Packaging, Eli Lilly & Co., Indiana, U.S.
Tomiyasu Hirachi, Advisor, Qualicaps Co. Ltd., Tokyo, Japan
John Nichols, Pharmaceutical Technology Director, Foster Wheeler, Berkshire, United Kingdom